Since 1995, Reliable Business Intelligence for Clinical Laboratories, Pathology Groups and Laboratory Diagnostics


hematology tests

FDA Clears Waived CBC For Near-Patient Testing

CEO SUMMARY: Market clearance of the first-ever CLIA-waived analyzer for complete blood count and three-part differential tests could cut time-to-answer from days to mere minutes for one of the top 20 tests by volume performed at core laboratories. Developer Sysmex America, Inc., foresees…

Read More

Office-Based Physicians Want In-Clinic Laboratories

CEO SUMMARY: Interest by office-based physicians in creating an in-clinic medical testing laboratory is on the increase. This has direct consequences for independent commercial labs, hospital lab outreach programs, and anatomic pathology groups, since office- based physicians are…

Read More

Key Trends Drive Change for Clinical Laboratories

CEO SUMMARY: Technology plays an ever-growing role in reshaping the organization and operation of clinical laboratories. New technologies figure prominently in THE DARK REPORT’S 2007 list of key trends in the clinical laboratory industry. Technological advances in instr…

Read More

Lab Competitors Pool Lab Data For Clinicians In British Columbia

CEO SUMMARY: In British Columbia, two commercial laboratory competitors have found common ground. BC Biomedical Laboratories and MDS Metro Laboratories are using LOINC to link their laboratory test databases. Physicians use a single system to access their patient’s test results, regardl…

Read More

United Kingdom Soon to Tackle Consolidation of Hospital Labs

CEO SUMMARY: Consolidation and regionalization of hospital laboratory testing are not isolated phenomenons. Beginning in the late 1980s, individual provinces in Canada began to rationalize lab testing services by building core labs and consolidating lab services across multiple hospitals….

Read More

“State of Lab Industry” Holds Surprises for All

CEO SUMMARY: Say goodbye to several of the trends which shaped the lab industry during the 1990s, such as consolidation and government compliance programs. Although these trends won’t completely disappear, they will be superseded by a number of new transformational influences. During th…

Read More

Abbott, CARESIDE, Bio-Reference Labs, DIANON Systems

SWARM OF LAWSUITS NOW PLAGUES ABBOTT LABS PAYING A $100 MILLION FINE TO THE Food and Drug Administration (FDA) did not end Abbott Laboratories, Inc.’s problems related to its diagnostic test kits and reagents. Since payment of the FDA fine last month, Abbott has been serv…

Read More

1999’s Top Ten Stories Reflect Speed of Change

CEO SUMMARY: This year’s round-up of the lab industry’s Top Ten most important stories lacks any compelling single theme. THE DARK REPORT’s conclusion? 1999 was a transition year. No new outside forces rattled the lab industry, allowing lab executives and pathologists to concentrate…

Read More

Opening Pandora’s Box

OUR EDITOR ONCE AGAIN HAS ANOTHER REMARKABLE PREDICTION for the clinical laboratory industry. In this issue, he predicts new point-of-care (POC) technology for routine chemistry and hematology testing will start the long- foretold process of laboratory decentralization. This follows on the heels of t…

Read More

Point-Of-Care Chemistry Ready To Transform Labs

CEO SUMMARY: Following on the heels of our prediction about web-based test ordering/results reporting, here’s another equally revolutionary development. CARESIDE, Inc. is ready to launch a point-of-care instrument suite for routine, high-volume chemistry and hematology tests. Early peek…

Read More

How Much Laboratory Business Intelligence Have You Missed?

Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!

Sign up for TDR Insider

Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.